SCHEMBL4694444

SCHEMBL4694444

CCOC(=O)N(C)c1c2c(c(O)c3ncccc13)C(=O)N(Cc1ccc(F)cc1)C2C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
TACR1 P25103 4/20 0.36
CNR2 P34972 4/20 0.36
CNR1 P21554 1/20 0.36
MAPT P10636 5/20 0.36
KMT2A Q03164 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
HTT P42858 2/20 0.36
RAB9A P51151 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
MPI P34949 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 6/20 0.35
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 3/20 0.34
ALOX12 P18054 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14573822 0.93 TSHR (0.41) TSHRTACR1CNR2CNR1MAPT
SCHEMBL4695318 0.86 TSHR (0.37) TSHRTACR1MAPTKMT2AMEN1
SCHEMBL14573729 0.86 TSHR (0.37) TSHRTACR1MAPTKMT2AMEN1
SCHEMBL4693921 0.83 COMT (0.38) TSHRTACR1CNR2CNR1MAPT
SCHEMBL4690020 0.83 COMT (0.38) TSHRTACR1CNR2CNR1MAPT
SCHEMBL4690017 0.83 COMT (0.38) TSHRTACR1CNR2CNR1MAPT
SCHEMBL5649171 0.81 KMT2A (0.40) TSHRTACR1CNR2CNR1MAPT
SCHEMBL4904131 0.80 CNR2 (0.37) TSHRTACR1CNR2CNR1MAPT
SCHEMBL4142618 0.80 CNR2 (0.40) TSHRTACR1CNR2CNR1MAPT
SCHEMBL14573798 0.79 TACR1 (0.31) TSHRTACR1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1888581-A2 HIV-INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2008-02-20 EP disclosed
US-20070072831-A1 Integrase inhibitor compounds GILEAD SCIENCES, INC. 2007-03-29 US disclosed
US-20070072831-A1 Integrase inhibitor compounds GILEAD SCIENCES, INC. 2007-03-29 US disclosed
US-20070072831-A1 Integrase inhibitor compounds GILEAD SCIENCES, INC. 2007-03-29 US disclosed
WO-2006125048-A2 HIV-INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072831-A1 Integrase inhibitor compounds TYMP, CDKN1A, PAICS TSHR 4773/4885TACR1 4662/4885CNR2 4717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.